EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre
Read moreEastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.
Read moreEastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives
Read moreEastgate Biotech Corp. CEO Anna Gluskin's interview with Uptick Newswire on October 17, 2018
Read moreAnna Gluskin's interview with Uptick Network on October 17, 2018
Read moreAnna Gluskin, CEO, Eastgate Biotech Corp. Interview on Uptick Network on 17Oct.2018
Read moreEastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution Non-Dilutive Investment and Product License includes licensing fee and development costs
Read moreEastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement.
Read moreGenome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company’s Joint Venture Partner
Read moreFocus on the manufacturing of the company’s liquid insulin mouth rinse solution for specific markets. Presently, EastGate is developing its insulin mouth rinse in the Philippines, Pakistan, and Europe through its JV with Nico Innovapharma.
Read more